Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference | Zendy

Vlado Perkovic | Zendy; Rajiv Agarwal | Zendy; Paola Fioretto | Zendy; Brenda R. Hemmelgarn | Zendy; Adeera Levin | Zendy; Merlin C. Thomas | Zendy; Christoph Wanner | Zendy; Bertram L. Kasiske | Zendy; David C. Wheeler | Zendy; PerHenrik Groop | Zendy; George L. Bakris | Zendy; Mark E. Cooper | Zendy; DongWan Chae | Zendy; Michael H. Davidson | Zendy; Ian H. de Boer | Zendy; Dick de Zeeuw | Zendy; Alessia Fori | Zendy; Luigi Gnudi | Zendy; Charles A. Herzog | Zendy; Adriana M. Hung | Zendy; Tazeen H. Jafar | Zendy; Meg Jardine | Zendy; Vivekanand Jha | Zendy; Lig Ji | Zendy; Steven E. Kahn | Zendy; Robyn G. Langham | Zendy; Edgar V. Lerma | Zendy; Ronald C.W. | Zendy; Hirofumi Makino | Zendy; Michel Marre | Zendy; Michael Mauer | Zendy; Kaj Metsärinne | Zendy; Robert G. Nelson | Zendy; Roberto Pecoits–Filho | Zendy; Carol A. Pollock | Zendy; Mohan Rajapurkar | Zendy; Peter Rossing | Zendy; Ivan Rychlík | Zendy; Kumar Sharma | Zendy; Robert C. Stanton | Zendy; Vladimı́r Tesař | Zendy; Ilkka Tikkanen | Zendy; Charles Tomson | Zendy; Robert D. Toto | Zendy; Yusuke Tsukamoto | Zendy; Katherine R. Tuttle | Zendy; Takashi Wada | Zendy; Winfred W. Williams | Zendy; Hong Zhang | Zendy; Sophia Zoungas | Zendy

Open Access

Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Author(s) -

Vlado Perkovic,

Rajiv Agarwal,

Paola Fioretto,

Brenda R. Hemmelgarn,

Adeera Levin,

Merlin C. Thomas,

Christoph Wanner,

Bertram L. Kasiske,

David C. Wheeler,

PerHenrik Groop,

George L. Bakris,

Mark E. Cooper,

DongWan Chae,

Michael H. Davidson,

Ian H. de Boer,

Dick de Zeeuw,

Alessia Fori,

Luigi Gnudi,

Charles A. Herzog,

Adriana M. Hung,

Tazeen H. Jafar,

Meg Jardine,

Vivekanand Jha,

Lig Ji,

Steven E. Kahn,

Robyn G. Langham,

Edgar V. Lerma,

Ronald C.W.,

Hirofumi Makino,

Michel Marre,

Michael Mauer,

Kaj Metsärinne,

Robert G. Nelson,

Roberto Pecoits–Filho,

Carol A. Pollock,

Mohan Rajapurkar,

Peter Rossing,

Ivan Rychlík,

Kumar Sharma,

Robert C. Stanton,

Vladimı́r Tesař,

Ilkka Tikkanen,

Charles Tomson,

Robert D. Toto,

Yusuke Tsukamoto,

Katherine R. Tuttle,

Takashi Wada,

Winfred W. Williams,

Hong Zhang,

Sophia Zoungas

Publication year - 2016

Publication title -

kidney international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.499

H-Index - 276

eISSN - 1523-1755

pISSN - 0085-2538

DOI - 10.1016/j.kint.2016.09.010

Subject(s) - medicine , kidney disease , diabetes mellitus , glycemic , intensive care medicine , disease , population , renal function , type 2 diabetes , cause of death , endocrinology , environmental health

The prevalence of diabetes around the world has reached epidemic proportions and is projected to increase to 642 million people by 2040. Diabetes is already the leading cause of end-stage kidney disease (ESKD) in most developed countries, and the growth in the number of people with ESKD around the world parallels the increase in diabetes. The presence of kidney disease is associated with a markedly elevated risk of cardiovascular disease and death in people with diabetes. Several new therapies and novel investigational agents targeting chronic kidney disease patients with diabetes are now under development. This conference was convened to assess our current state of knowledge regarding optimal glycemic control, current antidiabetic agents and their safety, and new therapies being developed to improve kidney function and cardiovascular outcomes for this vulnerable population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research